Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|June 6, 2026
Statistical modeling and enhanced performance of a hybrid catalytic photomicroelectrolysis (CPMC) system for tetracycline removal: a Box-Behnken design approachHakimeh Mahdizadeh, Majid Amiri Gharaghani, Yousef Dadban Shahamat, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|September 9, 2024
Identification and Prioritization of Health Indexes in Nomadic Tribespeople by Fuzzy Delphi Method: An Ecological StudyAtefeh Neamati, Hassan Hashemi, Mohammad Reza Samaei, et al.
Journal of the International AIDS Society|July 18, 2009
Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIVPayam Tabarsi, Ali S Saber-Tehrani, Parvaneh Baghaei, et al.
Journal of Clinical Microbiology|March 17, 2012
Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNACaroline Scholtes, Vinca Icard, Majid Amiri, et al.
Journal of Hazardous Materials|October 11, 2024
Assessment of drinking water quality and identifying pollution sources in a chromite mining regionAmin Mohammadpour, Ehsan Gharehchahi, Majid Amiri Gharaghani, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 13, 2009
Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patientsMohammad R Masjedi, Payam Tabarsi, Parvaneh Baghaei, et al.
Respirology (Carlton, Vic.)|January 17, 2008
Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in IranPayam Tabarsi, Azar Nooraki, Mehdi Mirsaeidi, et al.
Hepatitis Monthly|October 27, 2015
Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple TherapyPierre Pradat, Victor Virlogeux, Marianne Maynard, et al.
The American Journal of the Medical Sciences|March 21, 2009
Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteriaPayam Tabarsi, Parvaneh Baghaei, Parisa Farnia, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 3, 2010
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from IranPayam Tabarsi, Ehsan Chitsaz, Parvaneh Baghaei, et al.
Pageof 3